Search Results 191-200 of 17493 for quinine
About this study. The purpose of this study is to assess the safety, tolerability, movement (pharmcokinetics, "PK"), biological response (pharmacodynamics, ...
This first-in-human clinical trial is a Phase 1/1b, open-label, sequential-group, dose-escalation and cohort expansion study evaluating the safety, and ...
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial Of QPI-1007 In Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION). Print ...
Jeffrey R. Janus, M.D. · News · National Doctors' Day is March 30! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This study evaluates the safety and tolerability of extended dosing with ISIS-TTR Rx in patients with Familial Amyloid Polyneuropathy. Participation eligibility.
The purpose of this study is to determine if the use of Gilenya® can reduce neuropathy caused by paclitaxel. Participation eligibility. Participant eligibility ...
Data Analytics and AI for Advanced Liver Disease: Vijay Shah, Patrick Kamath, Douglas Simonetto, Alina Allen · Developmental Endoscopy: Elizabeth Rajan, Jad P.
The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!